Literature DB >> 31622623

Precision Treatment and Prevention of Colorectal Cancer-Hope or Hype?

Charles Muller1, Matthew Yurgelun2, Sonia S Kupfer3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31622623      PMCID： PMC6957699          DOI： 10.1053/j.gastro.2019.09.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  36 in total

1.  Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake.

Authors:  Joanna Watson; Keith Shaw; Maria Macgregor; Steve Smith; Stephen Halloran; Julietta Patnick; Valerie Beral; Jane Green
Journal:  J Med Screen       Date:  2013-10-31       Impact factor: 2.136

2.  Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.

Authors:  Andrea Sartore-Bianchi; Livio Trusolino; Cosimo Martino; Katia Bencardino; Sara Lonardi; Francesca Bergamo; Vittorina Zagonel; Francesco Leone; Ilaria Depetris; Erika Martinelli; Teresa Troiani; Fortunato Ciardiello; Patrizia Racca; Andrea Bertotti; Giulia Siravegna; Valter Torri; Alessio Amatu; Silvia Ghezzi; Giovanna Marrapese; Laura Palmeri; Emanuele Valtorta; Andrea Cassingena; Calogero Lauricella; Angelo Vanzulli; Daniele Regge; Silvio Veronese; Paolo M Comoglio; Alberto Bardelli; Silvia Marsoni; Salvatore Siena
Journal:  Lancet Oncol       Date:  2016-04-20       Impact factor: 41.316

3.  Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Authors:  Andrew M D Wolf; Elizabeth T H Fontham; Timothy R Church; Christopher R Flowers; Carmen E Guerra; Samuel J LaMonte; Ruth Etzioni; Matthew T McKenna; Kevin C Oeffinger; Ya-Chen Tina Shih; Louise C Walter; Kimberly S Andrews; Otis W Brawley; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Rebecca L Siegel; Richard C Wender; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2018-05-30       Impact factor: 508.702

4.  Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.

Authors:  Wade S Samowitz; Carol Sweeney; Jennifer Herrick; Hans Albertsen; Theodore R Levin; Maureen A Murtaugh; Roger K Wolff; Martha L Slattery
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

5.  When "Actionable" Genomic Sequencing Results Cannot Be Acted Upon.

Authors:  Brian J Zikmund-Fisher
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

6.  Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

Authors:  Stephanie L Schmit; Christopher K Edlund; Fredrick R Schumacher; Jian Gong; Tabitha A Harrison; Jeroen R Huyghe; Chenxu Qu; Marilena Melas; David J Van Den Berg; Hansong Wang; Stephanie Tring; Sarah J Plummer; Demetrius Albanes; M Henar Alonso; Christopher I Amos; Kristen Anton; Aaron K Aragaki; Volker Arndt; Elizabeth L Barry; Sonja I Berndt; Stéphane Bezieau; Stephanie Bien; Amanda Bloomer; Juergen Boehm; Marie-Christine Boutron-Ruault; Hermann Brenner; Stefanie Brezina; Daniel D Buchanan; Katja Butterbach; Bette J Caan; Peter T Campbell; Christopher S Carlson; Jose E Castelao; Andrew T Chan; Jenny Chang-Claude; Stephen J Chanock; Iona Cheng; Ya-Wen Cheng; Lee Soo Chin; James M Church; Timothy Church; Gerhard A Coetzee; Michelle Cotterchio; Marcia Cruz Correa; Keith R Curtis; David Duggan; Douglas F Easton; Dallas English; Edith J M Feskens; Rocky Fischer; Liesel M FitzGerald; Barbara K Fortini; Lars G Fritsche; Charles S Fuchs; Manuela Gago-Dominguez; Manish Gala; Steven J Gallinger; W James Gauderman; Graham G Giles; Edward L Giovannucci; Stephanie M Gogarten; Clicerio Gonzalez-Villalpando; Elena M Gonzalez-Villalpando; William M Grady; Joel K Greenson; Andrea Gsur; Marc Gunter; Christopher A Haiman; Jochen Hampe; Sophia Harlid; John F Harju; Richard B Hayes; Philipp Hofer; Michael Hoffmeister; John L Hopper; Shu-Chen Huang; Jose Maria Huerta; Thomas J Hudson; David J Hunter; Gregory E Idos; Motoki Iwasaki; Rebecca D Jackson; Eric J Jacobs; Sun Ha Jee; Mark A Jenkins; Wei-Hua Jia; Shuo Jiao; Amit D Joshi; Laurence N Kolonel; Suminori Kono; Charles Kooperberg; Vittorio Krogh; Tilman Kuehn; Sébastien Küry; Andrea LaCroix; Cecelia A Laurie; Flavio Lejbkowicz; Mathieu Lemire; Heinz-Josef Lenz; David Levine; Christopher I Li; Li Li; Wolfgang Lieb; Yi Lin; Noralane M Lindor; Yun-Ru Liu; Fotios Loupakis; Yingchang Lu; Frank Luh; Jing Ma; Christoph Mancao; Frank J Manion; Sanford D Markowitz; Vicente Martin; Koichi Matsuda; Keitaro Matsuo; Kevin J McDonnell; Caroline E McNeil; Roger Milne; Antonio J Molina; Bhramar Mukherjee; Neil Murphy; Polly A Newcomb; Kenneth Offit; Hanane Omichessan; Domenico Palli; Jesus P Paredes Cotoré; Julyann Pérez-Mayoral; Paul D Pharoah; John D Potter; Conghui Qu; Leon Raskin; Gad Rennert; Hedy S Rennert; Bridget M Riggs; Clemens Schafmayer; Robert E Schoen; Thomas A Sellers; Daniela Seminara; Gianluca Severi; Wei Shi; David Shibata; Xiao-Ou Shu; Erin M Siegel; Martha L Slattery; Melissa Southey; Zsofia K Stadler; Mariana C Stern; Sebastian Stintzing; Darin Taverna; Stephen N Thibodeau; Duncan C Thomas; Antonia Trichopoulou; Shoichiro Tsugane; Cornelia M Ulrich; Franzel J B van Duijnhoven; Bethany van Guelpan; Joseph Vijai; Jarmo Virtamo; Stephanie J Weinstein; Emily White; Aung Ko Win; Alicja Wolk; Michael Woods; Anna H Wu; Kana Wu; Yong-Bing Xiang; Yun Yen; Brent W Zanke; Yi-Xin Zeng; Ben Zhang; Niha Zubair; Sun-Seog Kweon; Jane C Figueiredo; Wei Zheng; Loic Le Marchand; Annika Lindblom; Victor Moreno; Ulrike Peters; Graham Casey; Li Hsu; David V Conti; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

7.  Clinical next generation sequencing to identify actionable aberrations in a phase I program.

Authors:  Genevieve M Boland; Sarina A Piha-Paul; Vivek Subbiah; Mark Routbort; Shelley M Herbrich; Keith Baggerly; Keyur P Patel; Lauren Brusco; Chacha Horombe; Aung Naing; Siqing Fu; David S Hong; Filip Janku; Amber Johnson; Russell Broaddus; Raja Luthra; Kenna Shaw; John Mendelsohn; Gordon B Mills; Funda Meric-Bernstam
Journal:  Oncotarget       Date:  2015-08-21

8.  Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study.

Authors:  Eric Van Cutsem; Sanne Huijberts; Axel Grothey; Rona Yaeger; Pieter-Jan Cuyle; Elena Elez; Marwan Fakih; Clara Montagut; Marc Peeters; Takayuki Yoshino; Harpreet Wasan; Jayesh Desai; Fortunato Ciardiello; Ashwin Gollerkeri; Janna Christy-Bittel; Kati Maharry; Victor Sandor; Jan H M Schellens; Scott Kopetz; Josep Tabernero
Journal:  J Clin Oncol       Date:  2019-03-20       Impact factor: 44.544

9.  Risk Scores for Predicting Advanced Colorectal Neoplasia in the Average-risk Population: A Systematic Review and Meta-analysis.

Authors:  Le Peng; Korbinian Weigl; Daniel Boakye; Hermann Brenner
Journal:  Am J Gastroenterol       Date:  2018-10-12       Impact factor: 10.864

10.  Clinical utility of circulating cell-free DNA in advanced colorectal cancer.

Authors:  Allan A Lima Pereira; Maria Pia Morelli; Michael Overman; Bryan Kee; David Fogelman; Eduardo Vilar; Imad Shureiqi; Kanwal Raghav; Cathy Eng; Shanequa Manuel; Shadarra Crosby; Robert A Wolff; Kimberly Banks; Richard Lanman; AmirAli Talasaz; Scott Kopetz; Van Morris
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240
View more
  1 in total

1.  Establishment and characterization of a new human colon cancer cell line, PUMC-CRC1.

Authors:  Xiaocui Bian; Fang Cao; Xiaowan Wang; Yuhong Hou; Haitao Zhao; Yuqin Liu
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.